04.23.15
StriVectin as linked up with skin imaging firm mySkin to Offer StriVectin Transdermal Skin Analysis featuring dermograph, a diagnostic tool giving consumers a holistic understanding of their own skin's needs.
mySkin is the maker of OKU, which was profiled in Happi's February 2015 feature on skin care devices.
A non-invasive hand-held device objectively measures overall skin health and is is the only system to analyze all five key variables that determine skin condition: moisture, texture, luminosity, discoloration and elasticity/firmness, according to StriVectin Using a safe, proprietary light source, the device is the only one of its kind able to illuminate and measure two millimeters below the skin surface, generating a scientific analysis that is translated into an easily digestible report, according to the companies.
The process takes 10 minutes, and a unique, personalized product recommendation is created as a prescriptive solution to address specific skincare concerns.
"We are thrilled to be the first brand to offer this amazing technology to consumers at a retail level. With the help of mySkin's dermograph, consumers will really be able to understand their skin and what they can do to help it. The skincare landscape is complicated, and we understand that it can be hard for consumers to navigate. What was once only found at doctors' offices and industry events is now available at point of sale—during the shopping experience," said JuE Wong, CEO of StriVectin.
The StriVectin Transdermal Skin Analysis featuring dermograph will be offered at various StriVectin retailer events in both the US and Canada, beginning this month.
mySkin is the maker of OKU, which was profiled in Happi's February 2015 feature on skin care devices.
A non-invasive hand-held device objectively measures overall skin health and is is the only system to analyze all five key variables that determine skin condition: moisture, texture, luminosity, discoloration and elasticity/firmness, according to StriVectin Using a safe, proprietary light source, the device is the only one of its kind able to illuminate and measure two millimeters below the skin surface, generating a scientific analysis that is translated into an easily digestible report, according to the companies.
The process takes 10 minutes, and a unique, personalized product recommendation is created as a prescriptive solution to address specific skincare concerns.
"We are thrilled to be the first brand to offer this amazing technology to consumers at a retail level. With the help of mySkin's dermograph, consumers will really be able to understand their skin and what they can do to help it. The skincare landscape is complicated, and we understand that it can be hard for consumers to navigate. What was once only found at doctors' offices and industry events is now available at point of sale—during the shopping experience," said JuE Wong, CEO of StriVectin.
The StriVectin Transdermal Skin Analysis featuring dermograph will be offered at various StriVectin retailer events in both the US and Canada, beginning this month.